SARS-CoV-2 mRNA booster vaccine-associated lichenoid drug eruption.

Mintoff, D; Pisani, D; Livori, N; Said-Huntingford, I; Baldacchino, G

Mintoff, D; Pisani, D; Livori, N; Said-Huntingford, I; Baldacchino, G.

Mintoff D; Department of Dermatology, Mater Dei Hospital, Msida, Malta.
Pisani D; Division of Histopathology, Department of Pathology, Mater Dei Hospital, Msida, Malta.
Livori N; Department of Dermatology, Mater Dei Hospital, Msida, Malta.
Said-Huntingford I; Division of Histopathology, Department of Pathology, Mater Dei Hospital, Msida, Malta.
Baldacchino G; Department of Dermatology, Mater Dei Hospital, Msida, Malta.

J Eur Acad Dermatol Venereol ; 36(8): e617-e619, 2022 08.

Article in English | MEDLINE | ID: covidwho-2272255

Subject(s)

COVID-19; Drug Eruptions; Lichen Planus; Vaccines; Antibodies, Viral; COVID-19/prevention & control; Drug Eruptions/etiology; Humans; RNA, Messenger; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / Drug Eruptions / COVID-19 / Lichen Planus Topics: Vaccines Limits: Humans Language: English Journal: J Eur Acad Dermatol Venereol Journal subject: Dermatology / Sexually Transmitted Diseases Year: 2022 Document Type: Article Affiliation country: Jdv.18149

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google